Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
89507 trials found · Page 117 of 4476
-
AI could revolutionize newborn screening for rare metabolic diseases
Diagnosis Not yet recruitingThe goal of this clinical trial is to evaluate whether an artificial intelligence (AI)-based interpretation system can accurately diagnose inherited metabolic disorders in newborns undergoing routine screening. The main questions it aims to answer are: What is the sensitivity an…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Diagnosis
Last updated May 01, 2026 16:01 UTC
-
New hope for ventilated kids: antibiotic mist may stop deadly pneumonia
Prevention Not yet recruitingThe goal of this clinical trial is to learn if nebulized colistimethate sodium can prevent pneumonia in ventilated children. The main question it aims to answer is: • Does nebulized colistimethate sodium lower the number of times participants develop ventilation associated pneum…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Fattouma Bourguiba • Aim: Prevention
Last updated Apr 29, 2026 15:02 UTC
-
Cuddle therapy may shield preemie brains from bleeding
Prevention Not yet recruitingThis clinical study aims to find out whether kangaroo care (skin-to-skin contact between parents and their extremely premature newborns) can help protect the babies' brains by reducing the risk of bleeding in the brain during the first days of life. To do this, the extremely prem…
Phase: NA • Sponsor: Hospital Universitario 12 de Octubre • Aim: Prevention
Last updated May 03, 2026 09:08 UTC
-
Hope for skin leishmaniasis: new drug combo trial launches in ethiopia
Disease control Not yet recruitingMAMS4CL comprises a clinical trial with three embedded sub-studies designed to comprehensively evaluate the administered treatments and assess the impact of CL treatment on patients and the healthcare system. The multi-centre multi-arm multi-stage phase 3 clinical trial is desig…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Cord stem cells aim to restore brain function after stroke
Disease control TerminatedThis is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period.
Phase: PHASE1, PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Stem cell hope for hip bone death: can cord cells save the joint?
Disease control TerminatedThe purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
Phase: PHASE1, PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 03, 2026 09:09 UTC
-
Experimental CAR-T therapy targets tough blood cancers in new trial
Disease control Not yet recruitingThis study is a single-arm, multicenter Investigator-Initiated Trial (IIT) clinical study. The primary objective is to evaluate the safety, pharmacokinetic characteristics, and preliminary efficacy of CAR-T cells in subjects with relapsed/refractory (r/r) CD7-positive hematologic…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Heart stents vs. pills: which works better for failing hearts?
Disease control Not yet recruitingTo evaluate whether percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) combined with guideline-directed medical therapy (GDMT), compared to GDMT alone, reduces the time to first occurrence of major adverse cardiovascular events (MACE) through 12 …
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New hope for stomach cancer: drug combo aims to shrink tumors before surgery
Disease control Not yet recruitingExploring the pathological complete response rate (pCR) of locally advanced gastric cancer treated with adebelimab combined or not combined with apatinib mesylate and SOX neoadjuvant therapy
Phase: PHASE3 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated May 03, 2026 09:11 UTC
-
Engineered immune cells target deadly brain tumors in early trial
Disease control Not yet recruitingThis phase I trial studies the side effects and best dose of EGFR/IL13Rα2 pool-chimeric antigen receptor (CAR) T cells when given through a thin, flexible tube into the brain (locoregional administration) in treating patients with high-grade gliomas that have come back after a pe…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Engineered virus takes on deadly brain cancer in early trial
Disease control Not yet recruitingThe goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New combo therapy targets tough pancreatic tumors
Disease control Not yet recruitingThe purpose of this study is to determine whether a new treatment combining radiation therapy with PCX12 is safe and tolerable.
Phase: PHASE1 • Sponsor: Haoming (Carl) Qiu • Aim: Disease control
Last updated May 03, 2026 09:04 UTC
-
Family donor immune cells take on post-transplant viruses in new trial
Disease control Not yet recruitingPatients with refractory ADV or CMV infection post allogeneic stem cell transplant will be randomized to either Family donor-derived viral specific cytotoxic T lymphocytes (CTLs) plus standard of care (SOC) vs SOC alone.
Phase: PHASE3 • Sponsor: New York Medical College • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
Smart MRI could help surgeons see and remove more brain cancer
Disease control Not yet recruitingThis phase III trial compares pH weighted chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI)-based surgical resections to standard of care surgical resections for the treatment of patients with glioblastoma. Standard of care therapy for glioblastoma is …
Phase: PHASE3 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 03, 2026 09:05 UTC
-
New drug combo aims to stop HPV head and neck cancer recurrence
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer who have detectable minimal-residual disease after definitiv…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New combo therapy before surgery may boost sinus cancer outcomes
Disease control Recruiting nowThis phase II trial compares the effect of chemotherapy (carboplatin and paclitaxel) with versus without cemiplimab given before surgery (neoadjuvant) in patients with sinonasal squamous cell cancer. Carboplatin is in a class of medications known as platinum-containing compounds.…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 03, 2026 09:08 UTC
-
Could stem cells ease Parkinson's symptoms? new trial launches
Disease control Not yet recruitingThis clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments t…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated May 03, 2026 09:04 UTC
-
New hope for kids with MS: testing Easier-to-Take pills
Disease control Not yet recruitingIn this study, researchers will learn more about the study drugs diroximel fumarate (DRF) and dimethyl fumarate (DMF) in children with MS who may be experiencing relapses. Participants will be divided into 2 groups based on their weight: * Group A will include children who weig…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC
-
New Two-Drug combo tested for advanced melanoma in india
Disease control Not yet recruitingThe purpose of this study is to assess the safety and tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) in untreated, unresectable or metastatic melanoma participants in India
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
New combo aims to shield bone marrow during chemo for tough breast cancer
Disease control Not yet recruitingTriple negative breast cancer (TNBC) has attracted much attention due to its young age of onset, high aggressiveness, lack of clear therapeutic targets and poor clinical prognosis.Eribulin is a novel non-taxane anti-microtubule inhibitor with unique microtubule and non-microtubul…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC